Skip to main content
Log in

Effects of long-term dietary administration of estrogen receptor-beta agonist diarylpropionitrile on ovariectomized female ICR (CD-1) mice

  • Original Article
  • Published:
GeroScience Aims and scope Submit manuscript

Abstract

Diarylpropionitrile (DPN) is an estrogen receptor-β-specific agonist that has been linked to neuroprotection, preserving cognitive function with age, the suppression of anxiety-like behaviors, inhibition of cancer growth, and other positive properties. We hypothesized that DPN may have pro-longevity properties. DPN was administered via feed at a dose corresponding to approximately 3 mg/kg/day to ovariectomized female mice beginning at 7 months of age. Mice were followed for the duration of their lifespans while monitoring body mass, aspects of behavior, learning, memory, and frailty. DPN-treated mice gained more body mass over the first 2 years of age (17 months of the study). A test of voluntary running behavior at 24 months of age behavior revealed no deficits in DPN-treated mice, which were as likely as control mice to engage in extended bouts of wheel running, and did so at higher average speeds. DPN administration had anxiolytic-like effects when measured using an elevated plus maze at 9 months of age. A mouse frailty index was used to assess age-related changes. The correlation between age and frailty differed between control and DPN-treated mice. Overall, dietary DPN administration had some beneficial effects on the aging phenotype of ovariectomized female mice with few significant detrimental effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Arnold S, Beyer C (2009) Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J Neurochem 110:1–11

    Article  PubMed  CAS  Google Scholar 

  • Bains RS, Cater HL, Sillito RR, Chartsias A, Sneddon D, Concas D, Keskivali-Bond P, Lukins TC, Wells S, Acevedo Arozena A, Nolan PM, Armstrong JD (2016) Analysis of individual mouse activity in group housed animals of different inbred strains using a novel automated home cage analysis system. Behav Neurosci 10:1–12

    Google Scholar 

  • Bansal S, Chopra K (2015) Differential role of estrogen receptor modulators in depression-like behavior and memory impairment in rats with postmenopausal diabetes. Menopause 22:1117–1124

    Article  PubMed  Google Scholar 

  • Barreto G, Huang T-T, Giffard RG (2010) Age-related defects in sensorimotor activity, spatial learning and memory in C57BL/6 mice. J Neurosurg Anesthesiol 22:214–219

    Article  PubMed  PubMed Central  Google Scholar 

  • Barros RPA, Gustafsson J-A (2011) Estrogen receptors and the metabolic network. Cell Metab 14(3):289–299

    Article  PubMed  CAS  Google Scholar 

  • Bean LA, Ianov L, Foster TC (2014) Estrogen Receptors, the Hippocampus, and Memory. Neuroscientist 20(5):534–545

  • Bourin M (2015) Animal models for screening anxiolytic-like drugs: a perspective. Dialogues Clin Neurosci 17:295–303

    PubMed  PubMed Central  Google Scholar 

  • Brinton RD (2012) Translational animal models of human menopause: challenges and emerging opportunities. Endocrinology 153:3571–3578

    Article  CAS  Google Scholar 

  • Campos AC, Fogaca MV, Aguiar DC, Guimaraes FS (2013) Animal models of anxiety disorders and stress. Rev Bras Psiquiatr Suppl 2:S101–S111

    Article  Google Scholar 

  • Dutta S, Sengupta P (2016) Men and mice: relating their ages. Life Sci 152:244–248

    Article  PubMed  CAS  Google Scholar 

  • Eckel LA (2011) The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiol Behav 104:517–524

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ervin KS, Lymer JM, Matta R, Clipperton-Allen AE, Kavaliers M, Choleris E (2015) Estrogen involvement in social behavior in rodents: rapid and long-term actions. Horm Behav 74:53–76

    Article  PubMed  CAS  Google Scholar 

  • Giroux V, Bernatchez G, Carrier JC (2011) Chemopreventive effect of ERβSelective agonist on intestinal tumorigenesis in Apc(Min/+) mice. Mol Carcinog 50(5):35969

    Article  CAS  Google Scholar 

  • Green MR, McCormick CM (2016) Sex and stress steroids in adolescence: gonadal regulation of the hypothalamic-pituitary-adrenal axis in the rat. Gen Comp Endocrinol 234:110–116

    Article  PubMed  CAS  Google Scholar 

  • Hamilton DJ, Minze LJ, Kumar T, Cao TN, Lyon CJ, Geiger PC, Hsueh WA, Gupte AA (2016) Estrogen receptor alpha activation enhances mitochondrial function and systemic metabolism in high-fat-fed ovariectomized mice. Physiol Rep 4(17):e12913

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Han SK, Lee D, Lee H, Kim D, Son HG, Yang J-S, Lee S-J V, Kim S (2016) OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research. Oncotarget 7(35):56147–56152

  • Hong J, Stubbins RE, Smith RR, Harvey AE, Nunez NP (2009) Differential susceptibility to obesity between male, female, and ovariectomized female mice. Nutr J 8:11

    Article  PubMed  PubMed Central  Google Scholar 

  • Jacome LF, Gautreaux C, Inagaki T, Mohan G, Alves S, Lubbers LS, Luine V (2010) Estradiol and ERβ agonists enhance recognition memory, and DPN, an ERβ agonist, alters brain monoamines. Neurobiol Learn Mem 94(4):488–498

  • Lejri I, Grimm A, Eckert A (2018) Mitochondria, estrogen and female brain aging. Front Neurosci 10:124

    Article  Google Scholar 

  • Leo LM, Pamplona FA (2014) Elevated plus maze test to assess anxiety-like behavior in the mouse. Bio Protocol 4:1–8

    Article  Google Scholar 

  • Levine JA, Schleusner SJ, Jensen MD (2000) Energy expenditure of non-exercise activity. Am J Clin Nutr 72:1451–1454

    Article  PubMed  CAS  Google Scholar 

  • Liao T-L, Tzeng C-R, Yu C-L, Wang Y-P, Kao S-H (2015) Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis. Ann NY Acad Sci 1350:52–60

    Article  PubMed  CAS  Google Scholar 

  • Mancuso M, Leonardi S, Giardullo P, Pasquali E, Borra F, Stefano ID, Prisco MG, Tanori M, Scambia G, Majo VD, Pazzaglia S, Saran A, Gallo D (2011) The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apoptotic pathways. Cancer Lett 308:197–202

    Article  PubMed  CAS  Google Scholar 

  • Meyers MH, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA (2001) Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230–4251

    Article  PubMed  CAS  Google Scholar 

  • Motylewska E, Stasikowska O, Melen-Mucha G (2009) The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett 276:68–73

    Article  PubMed  CAS  Google Scholar 

  • Nikolic I, Liu D, Bell JA, Collins J, Steenbergen C, Murphy E (2007) Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 42:769–780

    Article  PubMed  CAS  Google Scholar 

  • Oyola MG, Portillo W, Reyna A, Foradori CD, Kudwa A, Hinds L, Handa RJ, Mani SK (2012) Anxiolytic effects and neuroanatomical targets of estrogen receptor-β (ERβ) activation by a selective ERβ agonist in female mice. Endocrinology 153(2):837–846

    Article  PubMed  CAS  Google Scholar 

  • Patisaul HB, Burke KT, Hinkle RE, Adewale HL, Shea D (2009) Systemic administration of diarylpropionitrile (DPN) or phytoestrogens does not affect anxiety-related behaviors in gonadally intact male rats. Horm Behav 55(2):319–328

    Article  PubMed  CAS  Google Scholar 

  • Pravettoni A, Mornati O, Martini PG, Marino M, Colciago CF, Motta M, Negri-Cesi P (2007) Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol Cell Endocrinol 263:46–54

    Article  PubMed  CAS  Google Scholar 

  • Rettberg JR, Yao J, Brinton RD (2014) Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 35:8–30

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld CS, Ferguson SA (2014) Barnes maze testing strategies with small and large rodent models. J Vis Expt 84:e51194

    Google Scholar 

  • Sarvari M, Kallo I, Hrabovszky E, Solymosi N, Rodolosse A, Liposits Z (2016) Long-term estrogen receptor beta agonist treatment modifies the hippocampal transcriptome in middle-aged ovariectomized rats. Front Cell Neurosci 10:149

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Strong R, Miller RA, Antebi A, Astle CM, Bogue M, Denzel MS, Fernandez E, Flurkey K, Hamilton KL, Lamming DW, Javors MA, de Magalhaes JP, Martinez PA, McCord JM, Miller BF, Muller M, Nelson JF, Ndukum J, Rainger GE, Richardson A, Sabatini DM, Salmon AB, Simpkins JW, Steegenga WT, Nadon NL, Harrison DE (2016) Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell 15:872–884

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vasconsuelo A, Milanesi L, Boland R (2013) Actions of 17β-estradiol and testosterone in the mitochondria and their implications in aging. Ageing Res Rev 12:907–917

    Article  PubMed  CAS  Google Scholar 

  • Walf AA, Frye CA (2005) ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 30:1598–1609

    Article  PubMed  CAS  Google Scholar 

  • Wegorzewska IN, Walters K, Weiser MJ, Cruthirds DF, Ewell E, Larco DO, Handa RJ, Wu TJ (2008) Postovariectomy weight gain in female rats is reversed by estrogen receptor alpha agonist propylpyrazoletriol. Am J Obstet Gynecol 199:67.e1–67.e5

    Article  CAS  Google Scholar 

  • Whitehead JC, Hildebrand BA, Sun M, Rockwood MR, Rose RA, Rockwood K, Howlett SE (2013) A clinical frailty index in aging mice: comparisons with frailty index data in humans. J Gerontol A Biol Sci Med Sci 69(6):621–632

    Article  PubMed  PubMed Central  Google Scholar 

  • Yakimchuk K, Hasni MS, Guan J, Chao MP, Sander B, Okret S (2014) Inhibition of lymphoma vascularization and dissemination by estrogen receptor b agonists. Blood 123(13):2054–2061

    Article  PubMed  CAS  Google Scholar 

  • Zhao L, Mao Z, Schneider LS, Brinton RD (2011) Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause. Menopause 18:1131–1142

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported in part by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to JAS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey A. Stuart.

Ethics declarations

All procedures were approved by the Animal Care and Use Committee at Brock University, in compliance with CCAC guidelines.

Electronic supplementary material

ESM 1

(DOCX 16 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Said, S.A., Isedowo, R., Guerin, C. et al. Effects of long-term dietary administration of estrogen receptor-beta agonist diarylpropionitrile on ovariectomized female ICR (CD-1) mice. GeroScience 40, 393–403 (2018). https://doi.org/10.1007/s11357-018-0038-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11357-018-0038-7

Keywords

Navigation